Patrizia buys cold storage logistics asset near Milan from Savills IM

Patrizia buys cold storage logistics asset near Milan from Savills IM

Patrizia has acquired a newly built cold storage logistics asset near Milan, Italy, from Savills Investment Management SGR S.p.A., on behalf of its institutional clients through one of its flagship logistics funds.

The c. 31,000 sq m cold storage asset was completed in Q2 2021 and is fully let to Kühne & Nagel, a leading pan-European 3rd party logistics company, and Movi.Log Srl, a frozen food distributor, with a WALT of 7.5 years. The property has been built to a high specification with sprinklers, elevations and ample refrigeration space that has a temperature range between 4°C and -28 °C. Sustainability was a key consideration during its development. The asset includes two photovoltaic plants for a total power capacity of 2.5MW and is targeting a BREEAM rating.

The property is located in Casorate Primo, a municipality in Lombardy between the cities of Milan and Pavia, a prime industrial and logistics location in northern Italy. It benefits from excellent transport connectivity via the nearby A7 motorway which connects Milan with Genoa and enables access to France and Switzerland.

Pierluigi Scialanga, Head of Transactions at Patrizia Italy, commented: “The property is well located and has excellent sustainability credentials, while lettings to tenants with strong covenants will deliver long term reliable returns. Our Italian AUM has grown significantly in recent years to now over EUR 1 billion with plans to grow further. Logistics is a strategic sector for Patrizia Italy. We have so far invested EUR 400 million in logistics and have a pipeline of a further EUR 160 million of logistics transactions which we are completing.”

Rob Brook, Head of Alternative Investments and Head of Logistics at Patrizia, added: “Cold chain is an exciting area of logistics for Patrizia to be involved in. Demand is predicted to grow steadily in the next few years, especially due to a growing need for reliable supply chains for biopharmaceuticals, vaccines and clinical trials. High demand across Europe combined with low vacancy rates makes cold chain logistics an ideal growth area for the future.”